Zeev Stegman, MD

Locations

Physician Office

911 Park Avenue, New York, NY, 10028

212-772-1703

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:13

Article:21

Review Article:1

Comment/Debate:1

Letter:1

Recent Artifacts

• Successful treatment of acute ocular graft-versus-host disease with tacrolimus (FK506) [3]
• Stem cells and differentiation stages in the limbo-corneal epithelium
• Differentiation-dependent expression of α-2,3-sialyltransferase in rabbit corneal epithelium
• High-resolution ultrasound biomicroscopy of the pars plana and peripheral retina
• Peter's anomaly: Diagnosis by ultrasound biomicroscopy
• Ultrasound biomicroscopy in anterior ocular trauma
• Mutually exclusive expression of connexins and α-enolase in the rat limbo-cornkal epithelium during development and in the adult
• Ciliary body enlargement and cyst formation in uveitis
• Ultrasound biomicroscopic features of iris retraction syndrome
• A new method of quantifying the anterior chamber angle with Ultrasound Biomicroscopy (UBM)

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Stegman has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.